0 – Cambridge Enterprise

Drugs

First of new generation of cancer drugs granted European approval

19 December 2014

Aqdot closes £2.55m funding round

17 December 2014

Jukedeck wins LeWeb Competition

12 December 2014

Sapientia: one step closer to fast, definitive diagnosis of rare genetic diseases

08 December 2014

Cambridge academics are winners in GSK’s Discovery Fast Track Challenge

01 December 2014

blue drugs and needle

FDA approves MS drug developed by University of Cambridge researchers

17 November 2014

Cambridge Epigenetix raises $5.5M

31 October 2014

Lynparza recommended for approval in ovarian cancer

24 October 2014

New Cambridge Enterprise office opens on Biomedical Campus

29 September 2014

Cropped shot of a male scientist conducting blood tests in a medical lab

Inivata raises £4m to improve cancer treatment through simple blood tests

23 September 2014

Shaun Formal

Breathing Buildings CEO Dr Fitzgerald Named Royal Academy Fellow

17 September 2014

Scientists reset human stem cells to earliest developmental state

12 September 2014